Toyooka; Naoki
Patent Applications and Registrations
Patent applications and USPTO patent grants for Toyooka; Naoki.The latest application filed is for "antipruritic agent using pac1 receptor antagonist".
- Toyooka; Naoki - Toyama JP
- TOYOOKA; Naoki - Toyama-shi Toyarna
| Patent | Date |
|---|---|
| Analgesic drug using PAC1 receptor antagonistic drug Grant 11,365,194 - Kurihara , et al. June 21, 2 | 2022-06-21 |
| Antipruritic Agent Using Pac1 Receptor Antagonist App 20220184081 - KURIHARA; Takashi ; et al. | 2022-06-16 |
| Analgesic Drug Using Pac1 Receptor Antagonistic Drug App 20210188841 - KURIHARA; Takashi ; et al. | 2021-06-24 |
| T-type Calcium Channel Inhibitor App 20200308132 - KAWABATA; Atsufumi ; et al. | 2020-10-01 |
| Serine racemase inhibitor Grant 9,216,954 - Mori , et al. December 22, 2 | 2015-12-22 |
| Serine Racemase Inhibitor App 20140371291 - Mori; Hisashi ; et al. | 2014-12-18 |
| Fused tricyclic compound having aldose reductase inhibitory activity Grant 8,198,447 - Toyooka , et al. June 12, 2 | 2012-06-12 |
| Fused Tricyclic Compound Having Aldose Reductase Inhibitory Activity App 20100145052 - TOYOOKA; Naoki ; et al. | 2010-06-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 